Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2021-08-13 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
关于子公司变更医疗器械生产许可证的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Guangzhou Yangpu Medical Technology Co., Ltd. regarding a change in the medical device production license of its subsidiary. It details the updated license information, the new product added to the production registration, and the expected impact on the company. The document is short (1301 characters) and focuses on regulatory approval and operational updates rather than financial data or report publication. It does not contain financial statements, earnings data, or management discussion. It is not a report or presentation but a regulatory announcement about a license change. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-08-13 Chinese
关于收到国家市场监督管理总局《经营者集中反垄断审查不实施进一步审查决定书》暨控制权变更事项进展的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Guangzhou Yangpu Medical Technology Co., Ltd. regarding the receipt of a decision from the State Administration for Market Regulation about an antitrust review related to a change in control of the company. It details a share transfer agreement and the resulting change in control, including regulatory approval of the transaction. The document does not contain financial statements or detailed financial data but rather provides an update on a capital transaction and control change. This fits the category of Capital/Financing Update (CAP), as it concerns share transfer, control change, and regulatory approval related to financing and ownership structure.
2021-08-09 Chinese
监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Guangzhou Yangpu Medical Technology Co., Ltd. regarding the approval of the company's 2021 semi-annual report and related investment authorization. It references the 2021 semi-annual report but does not contain the report itself or detailed financial statements. The document length is short (1057 characters) and it states that the full semi-annual report and summary are available on the designated disclosure website. This fits the pattern of a Regulatory Filing (RNS) as it is an official announcement about the approval of a report and related decisions, not the report itself. Therefore, the correct classification is Regulatory Filings (RNS).
2021-08-06 Chinese
董事会决议公告
Board/Management Information Classification · 95% confidence The document is a board meeting resolution announcement from Guangzhou Yangpu Medical Technology Co., Ltd. It details the approval of the 2021 semi-annual report and other board decisions. The text includes voting results and references to the actual semi-annual report being published elsewhere (on the designated disclosure website). The document itself does not contain the full semi-annual report or substantive financial data but rather announces the board's approval of that report and other resolutions. This fits the category of Board/Management Information (MANG), as it announces board meeting decisions and approvals. The document length is short (1076 characters), and it is not the report itself but an announcement of board resolutions.
2021-08-06 Chinese
2021年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2021 年半年度报告全文" which translates to "2021 Semi-Annual Report Full Text" for Guangzhou Improve Medical Instruments Co., Ltd. It contains detailed financial data, management discussion and analysis, company overview, business segments, and other comprehensive information typical of an interim or quarterly report. The report period is clearly stated as January 1, 2021 to June 30, 2021, which is a half-year period. The document length is substantial (15,000 characters), and it includes actual financial statements and substantive financial data and analysis, not just an announcement or summary. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2021
2021-08-06 Chinese
关于第五届董事会第十一次会议相关事项的独立意见
Regulatory Filings Classification · 95% confidence The document is an independent directors' opinion on matters discussed at the 11th meeting of the 5th board of Guangzhou Yangpu Medical Technology Co., Ltd. It references compliance with regulatory guidelines and company rules, discusses authorization for investment of idle funds, and provides a special statement on related party fund occupation and external guarantees for the 2021 half-year period. The document is a formal opinion letter from independent directors rather than a full financial report or announcement. It does not contain financial statements or detailed financial data, nor is it a simple announcement or certification. This type of document fits best under Regulatory Filings (RNS) as it is a regulatory compliance-related disclosure that does not fit other specific categories like Annual Report, Interim Report, or Audit Report.
2021-08-06 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.